The beneficial effects of the anti-AβO antibody fraction on cognitive functions in mouse models backs the presence of protective anti-AD natural antibodies (nAbs) that, due to immunosenescence, decrease with age when AD starts to appear [45]. The gene discussed is ABO; the disease is Alzheimer disease.